Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
Background. Pediatric inflammatory bowel disease (IBD) is on the rise worldwide. Endoscopies are necessary for IBD assessment but are invasive, expensive, and inconvenient. Recently, fecal calprotectin (FCal) was proposed as a noninvasive and specific marker of gut inflammation. We evaluated the ana...
Saved in:
Main Authors: | Saranya Kittanakom, Md. Sharif Shajib, Kristine Garvie, Joceline Turner, Dan Brooks, Sufian Odeh, Robert Issenman, V. Tony Chetty, Joseph Macri, Waliul I. Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2017/1450970 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fecal Calprotectin Use in Inflammatory Bowel Disease and Beyond: A Mini-Review
by: Bashaar Alibrahim, et al.
Published: (2015-01-01) -
The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
by: Esmail Abej, et al.
Published: (2016-01-01) -
Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis
by: Jiajia Li, et al.
Published: (2019-01-01) -
Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease
by: Brian Bressler, et al.
Published: (2015-01-01) -
Level of fecal neopterin and calprotectin in asymptomatic and symptomatic norovirus-infected children with malnutrition in Indonesia
by: Anisa Lailatul Fitria, et al.
Published: (2025-04-01)